Large-scale purification of factor VIII by affinity chromatography: optimization of process parameters

Journal of Chromatography
M P te BooyB W König

Abstract

The optimization of a new process for the extraction of human coagulation factor VIII (FVIII) from plasma with the tailor-made affinity matrix dimethylamino-propylcarbamylpentyl-Sepharose CL-4B (C3-C5 matrix) is described. First, plasma is applied to DEAE-Sephadex A-50 anion exchanger in order to separate a number of proteins, including coagulation factors II, IX and X (prothrombin complex), from FVIII. Subsequently, the unbound fraction of the ion exchanger, containing FVIII, is contacted with the C3-C5 affinity matrix. Optimization of the FVIII affinity chromatographic procedure is accomplished in terms of the ligand density of the matrix, adsorption mode (batch-wise versus column-wise adsorption and matrix to plasma ratio), and conditions of pH and conductivity to be applied on washing and desorption. In scale-up experiments, by processing 20 l of plasma, the recovery (340 U VIII:C/kg plasma) and the specific activity (s.a.) (1.2 U VIII:C/mg protein) are better than those obtained by cryoprecipitation (recovery 300 U VIII:C/kg plasma, s.a. 0.3 U VIII:C/mg protein). The newly developed process using the specially designed C3-C5 affinity matrix has potential application in the process-scale purification of FVIII.

Citations

Aug 15, 1994·Journal of Biotechnology·N Labrou, Y D Clonis
Nov 6, 2001·Journal of Biochemical and Biophysical Methods·A Tejeda-MansirR Guzmán
Nov 6, 2001·Journal of Biochemical and Biophysical Methods·T Burnouf, M Radosevich
May 23, 2000·Journal of Chromatography. B, Biomedical Sciences and Applications·A MurzaJ M Guisán
Oct 29, 1998·Journal of Chromatography. B, Biomedical Sciences and Applications·T BurnoufM Radosevich
Oct 29, 1998·Journal of Chromatography. B, Biomedical Sciences and Applications·P Kaersgaard, K A Barington
May 28, 2003·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·N E Labrou
Dec 10, 2009·Analytical Biochemistry·Allan LihmeThierry Burnouf

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.